Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Bleomycin Hydrolase (BLMH) (Middle Region) Peptide

BLMH Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN973829
$160.46
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 11 to 17 Business Days

Quick Overview for Bleomycin Hydrolase (BLMH) (Middle Region) Peptide (ABIN973829)

Target

BLMH (Bleomycin Hydrolase (BLMH))

Origin

Human

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-BLMH antibody (Catalog #: ARP56106_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    BLMH (Bleomycin Hydrolase (BLMH))

    Background

    The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity.Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution, however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: BH, BMH

    Protein Interaction Partner: APP,BLMH,KBTBD7,RPL11,RPL29,TRIO,UBE2I,APP,BLMH,KBTBD7,RPL11,RPL29,TRIO,UBE2I,USP53

    Protein Size: 455

    Molecular Weight

    52 kDa

    Gene ID

    642

    NCBI Accession

    NM_000386, NP_000377

    UniProt

    Q13867
You are here:
Chat with us!